{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:04:54Z","timestamp":1780027494937,"version":"3.53.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CVIR Endovasc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Liquid embolic agents (LEAs) have expanded the therapeutic options for complex vascular and non-vascular conditions. Tailored clinical assessment with dedicated procedure planning is critical in the selection of the most appropriate embolic to ensure procedural success and minimise complications. The LEAs, which range from sclerosant agents to glues and copolymers all have specific physical characteristics. Sclerosant agents are mainly selected for symptomatic vein diseases such as varicoceles and low-flow venous and lymphatic malformations (VM and LM), usually requiring multiple treatment sessions to achieve a satisfactory response. Glues and copolymers have completely different properties but may have overlapping indications ranging from haemorrhage control (gastrointestinal and solid-organ), treatment of visceral and renal aneurysms or pseudoaneurysms to type II endoleaks, arteriovenous malformations\/fistulas, tumour devascularisation, and selective end-organ embolisation. The use of each agent varies according to the specific clinical scenario, and operator experience and preference. This review aims to provide a concise and practical overview of the use of LEAs.<\/jats:p>","DOI":"10.1186\/s42155-026-00710-x","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T02:15:47Z","timestamp":1780020947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Liquid embolic agents\u2014a practical overview"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8411-1805","authenticated-orcid":false,"given":"Alessandro","family":"Cannavale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Ratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Mahnken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Alonso-Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique Esteban","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romaric","family":"Loffroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"710_CR1","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00270-021-02904-3","volume":"44","author":"AH Mahnken","year":"2021","unstructured":"Mahnken AH, Seoane EB, Cannavale A, de Haan MW, Dezman R, Kloeckner R, et al. CIRSE clinical practice manual. Cardiovasc Intervent Radiol. 2021;44:1323\u201353.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"710_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00270-015-1228-7","volume":"39","author":"B Taslakian","year":"2016","unstructured":"Taslakian B, Sebaaly MG, Al-Kutoubi A. Patient evaluation and preparation in vascular and interventional radiology: what every interventional radiologist should know (Part 1: Patient zssessment and laboratory tests). Cardiovasc Intervent Radiol. 2016;39:325\u201333.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"710_CR3","unstructured":"British Society of Interventional Radiology, British Society of Haematology. BSH Joint Guidance from the British Societies of Interventional Radiology and Haematology on Managing Bleeding Risk during Procedures in Interventional Radiology. Available at https:\/\/b-s-h.org.uk\/media\/udvdcvhh\/bsir-bsh-ir-bleeding-risk-guidance-2022.pdf?cf=638107532702030000"},{"key":"710_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.bjps.2015.10.045","volume":"69","author":"SE Horbach","year":"2016","unstructured":"Horbach SE, Lokhorst MM, Saeed P, de Go\u00fcyon Matignon de Pontouraude CM, Rothov\u00e1 A, van der Horst CM. Sclerotherapy for low-flow vascular malformations of the head and neck: a systematic review of sclerosing agents. J Plast Reconstr Aesthet Surg. 2016;69:295\u2013304.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"710_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/0268355514534648","volume":"30","author":"K Parsi","year":"2014","unstructured":"Parsi K. Interaction of detergent sclerosants with cell membranes. Phlebology. 2014;30:306\u201315.","journal-title":"Phlebology"},{"key":"710_CR6","first-page":"54","volume":"1","author":"L Tessari","year":"2001","unstructured":"Tessari L. Extemporary sclerosing foam according to personal method: experimental clinical data and catheter usage. Int Angiol Suppl. 2001;1:54.","journal-title":"Int Angiol Suppl"},{"key":"710_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108931","volume":"9","author":"L Han","year":"2014","unstructured":"Han L, Su W, Huang J, Zhou J, Qiu S, Liang D. Doxycycline inhibits inflammation-induced lymphangiogenesis in mouse cornea by multiple mechanisms. PLoS ONE. 2014;9:e108931.","journal-title":"PLoS ONE"},{"key":"710_CR8","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1007\/s00247-012-2406-2","volume":"42","author":"A Shergill","year":"2012","unstructured":"Shergill A, John P, Amaral JG. Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy. Pediatr Radiol. 2012;42:1080\u20138.","journal-title":"Pediatr Radiol"},{"key":"710_CR9","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/j.jpedsurg.2011.07.004","volume":"46","author":"AM Cahill","year":"2011","unstructured":"Cahill AM, Nijs E, Ballah D, Rabinowitz D, Thompson L, Rintoul N, et al. Percutaneous sclerotherapy in neonatal and infant head and neck lymphatic malformations: a single center experience. J Pediatr Surg. 2011;46:2083\u201395.","journal-title":"J Pediatr Surg"},{"key":"710_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jpedsurg.2007.09.049","volume":"43","author":"WE Shiels 2nd","year":"2008","unstructured":"Shiels WE 2nd, Kenney BD, Caniano DA, Besner GE. Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. J Pediatr Surg. 2008;43:136\u20139.","journal-title":"J Pediatr Surg"},{"issue":"2","key":"710_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.otohns.2009.04.001","volume":"141","author":"WE Shiels 2nd","year":"2009","unstructured":"Shiels WE 2nd, Kang DR, Murakami JW, Hogan MJ, Wiet GJ. Percutaneous treatment of lymphatic malformations. Otolaryngol Head Neck Surg. 2009;141(2):219\u201324.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"710_CR12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s00270-020-02420-w","volume":"43","author":"AL Cho","year":"2020","unstructured":"Cho AL, Kiang SC, Lodenkamp J, Tritch WTH, Tomihama RT. Fatal lung toxicity after intralesional bleomycin sclerotherapy of a vascular malformation. Cardiovasc Intervent Radiol. 2020;43:648\u201351.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"710_CR13","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.jvir.2015.05.007","volume":"26","author":"F Ul Haq","year":"2015","unstructured":"Ul Haq F, Mitchell SE, Tekes A, Weiss CR. Bleomycin foam treatment of venous malformations: a promising agent for effective treatment with minimal swelling. J Vasc Interv Radiol. 2015;26:1484\u201393.","journal-title":"J Vasc Interv Radiol"},{"key":"710_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/bja\/aen395","volume":"102","author":"G Kessell","year":"2009","unstructured":"Kessell G, Panchatsharam S, Kothmann E, Finn P, Fall A, Guhan A, et al. General anaesthesia for intralesional bleomycin therapy of vascular malformations: initial 3 yr experience. Br J Anaesth. 2009;102:431\u20132.","journal-title":"Br J Anaesth"},{"key":"710_CR15","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jvir.2018.10.007","volume":"30","author":"HC Milbar","year":"2019","unstructured":"Milbar HC, Jeon H, Ward MA, Mitchell SE, Weiss CR, Cohen BA. Hyperpigmentation after foamed bleomycin sclerotherapy for vascular malformations. J Vasc Interv Radiol. 2019;30:1438\u201342.","journal-title":"J Vasc Interv Radiol"},{"key":"710_CR16","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1097\/00042728-200712000-00006","volume":"33","author":"W Mol","year":"2007","unstructured":"Mol W, Furukawa H, Sasaki S, Tomaru U, Hayashi T, Saito A, et al. Evaluation of the sclerotherapeutic efficacy of ethanol, polidocanol, and OK-432 using an in vitro model. Dermatol Surg. 2007;33:1452\u20139.","journal-title":"Dermatol Surg"},{"key":"710_CR17","first-page":"1423","volume":"322","author":"A Stefanou","year":"2001","unstructured":"Stefanou A, Siderov J, Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Oncology. Medical errors. Dosage nomenclature of bleomycin needs to be standardized to avoid errors. BMJ. 2001;322:1423\u20134.","journal-title":"BMJ"},{"key":"710_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.4097\/kjae.2014.66.5.388","volume":"66","author":"JY Jo","year":"2014","unstructured":"Jo JY, Chin JH, Park PH, Ku SW. Cardiovascular collapse due to right heart failure following ethanol sclerotherapy: a case report. Korean J Anesthesiol. 2014;66:388\u201391.","journal-title":"Korean J Anesthesiol"},{"key":"710_CR19","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/01.RVI.0000133505.84588.8C","volume":"15","author":"JW Kish","year":"2004","unstructured":"Kish JW, Katz MD, Marx MV, Harrell DS, Hanks SE. N-butyl cyanoacrylate embolisation for control of acute arterial haemorrhage. J Vasc Interv Radiol. 2004;15:689\u201395.","journal-title":"J Vasc Interv Radiol"},{"key":"710_CR20","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S1051-0443(07)61568-1","volume":"12","author":"JS Pollak","year":"2001","unstructured":"Pollak JS, White J. The use of cyanoacrylate adhesives in peripheral embolisation. J Vasc Interv Radiol. 2001;12:907\u201313.","journal-title":"J Vasc Interv Radiol"},{"key":"710_CR21","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00270-025-03997-w","volume":"48","author":"PO Comby","year":"2025","unstructured":"Comby PO, Guillen K, Chevallier O, Couloumy E, Dencausse A, Robert P, et al. Embolic effect of different cyanoacrylates: radiological and histological comparison in an in vivo rabbit renal-artery model. Cardiovasc Intervent Radiol. 2025;48:823\u201333.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"710_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10194320","volume":"10","author":"PO Comby","year":"2021","unstructured":"Comby PO, Guillen K, Chevallier O, Lenfant M, Pellegrinelli J, Falvo N, et al. Endovascular use of cyanoacrylate-lipiodol mixture for peripheral embolisation: properties, techniques, pitfalls, and applications. J Clin Med. 2021;10:4320.","journal-title":"J Clin Med"},{"key":"710_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42155-025-00535-0","volume":"8","author":"H Sawalha","year":"2025","unstructured":"Sawalha H, Chevallier O, Fouad M, Makoto TT, Pierre-Olivier C, Aho-Glele LS, et al. Transcatheter arterial and venous embolisation with \u03b1-hexyl cyanoacrylate MagicGlue\u00ae: short-term safety and efficacy outcomes. CVIR Endovasc. 2025;8:1\u201310.","journal-title":"CVIR Endovasc"},{"key":"710_CR24","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.jvir.2012.06.022","volume":"23","author":"C Takasawa","year":"2012","unstructured":"Takasawa C, Seiji K, Matsunaga K, Matsuhashi T, Ohta M, Shida S, et al. Properties of n-butyl cyanoacrylate-iodized oil mixtures for arterial embolisation: In vitro and in vivo experiments. J Vasc Interv Radiol. 2012;23:1215\u201321.","journal-title":"J Vasc Interv Radiol"},{"key":"710_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/0284185113493774","volume":"55","author":"J Urbano","year":"2014","unstructured":"Urbano J, Cabrera M, Alonso-Burgos A. Sclerosis and varicocele embolisation with N-butyl cyanoacrylate: experience in 41 patients. Acta Radiol. 2014;55:179\u201385.","journal-title":"Acta Radiol"},{"key":"710_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1055\/s-0028-1085930","volume":"25","author":"S Vaidya","year":"2008","unstructured":"Vaidya S, Tozer KR, Chen J. An overview of embolic agents. Semin Intervent Radiol. 2008;25:204\u201315.","journal-title":"Semin Intervent Radiol"},{"key":"710_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051195","volume":"10","author":"D Kuetting","year":"2022","unstructured":"Kuetting D, Kupczyk P, Dell T, Luetkens JA, Meyer C, Attenberger UI, et al. In vitro evaluation of acrylic adhesives in lymphatic fluids-influence of glue type and procedural parameters. Biomedicines. 2022;10:1195.","journal-title":"Biomedicines"},{"key":"710_CR28","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00270-013-0810-0","volume":"37","author":"D Geisel","year":"2014","unstructured":"Geisel D, Malinowski M, Powerski MJ, W\u00fcstefeld J, Heller V, Denecke T, et al. Improved hypertrophy of future remnant liver after portal vein embolisation with plugs, coils and particles. Cardiovasc Intervent Radiol. 2014;37:1251\u20138.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"710_CR29","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00270-018-1885-4","volume":"41","author":"M Yamamoto","year":"2018","unstructured":"Yamamoto M, Yamada K, Horikawa M, Kondo H, Oba H, Furui S. Embolisation of the thoracic duct by direct injection of N-butyl-2-cyanoacrylate glue via a puncture needle. Cardiovasc Intervent Radiol. 2018;41:959\u201363.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"710_CR30","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s11255-024-04347-4","volume":"57","author":"E Lanza","year":"2025","unstructured":"Lanza E, Mininni A, Tomasino L, Ammirabile A, Ferrillo G, Romano S, et al. Long-term efficacy and catheter choice in male varicocele embolisation using NBCA-MS glue. Int Urol Nephrol. 2025;57:1707\u201314.","journal-title":"Int Urol Nephrol"},{"key":"710_CR31","doi-asserted-by":"publisher","first-page":"5464","DOI":"10.1007\/s00330-020-07685-w","volume":"31","author":"A Ali","year":"2021","unstructured":"Ali A, Ahle M, Bj\u00f6rnsson B, Sandstr\u00f6m P. Portal vein embolisation with N-butyl cyanoacrylate glue is superior to other materials: a systematic review and meta-analysis. Eur Radiol. 2021;31:5464\u201378.","journal-title":"Eur Radiol"},{"key":"710_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2025.102256","volume":"13","author":"JM Hipola","year":"2025","unstructured":"Hipola JM, Alonso A, C\u00e1rdenas R, Pillado E, Leal JI. Efficacy and safety of ovarian vein embolisation with N-butyl-2 cyanoacrylate for pelvic venous disorder: analysis of 100 cases. J Vasc Surg Venous Lymphat Disord. 2025;13:102256.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"710_CR33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1053\/j.tvir.2016.10.006","volume":"19","author":"J Kim","year":"2016","unstructured":"Kim J, Won JH. Percutaneous treatment of chylous ascites. Tech Vasc Interv Radiol. 2016;19:291\u20138.","journal-title":"Tech Vasc Interv Radiol"},{"key":"710_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.diii.2023.12.006","volume":"105","author":"R Loffroy","year":"2024","unstructured":"Loffroy R, Quirantes A, Guillen K, Mazit A, Comby PO, Aho-Gl\u00e9l\u00e9 LS, et al. Prostate artery embolisation using n-butyl cyanoacrylate glue for symptomatic benign prostatic hyperplasia: a six-month outcome analysis in 103 patients. Diagn Interv Imaging. 2024;105:129\u201336.","journal-title":"Diagn Interv Imaging"},{"key":"710_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jvir.2023.09.019","volume":"35","author":"J Sanghvi","year":"2024","unstructured":"Sanghvi J, Bamshad D, Galla N, Bai H, Garcia-Reyes K, Fischman A. Fluoroscopy time and radiation dose using liquid embolic (n-butyl-2-cyanoacrylate) versus microspheres for prostatic artery embolisation. J Vasc Interv Radiol. 2024;35:147-51.e1.","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"710_CR36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jvir.2024.09.011","volume":"36","author":"R Loffroy","year":"2025","unstructured":"Loffroy R. The concept of prostatic artery occlusion with cyanoacrylate glue: a potential game changer. J Vasc Interv Radiol. 2025;36:184.","journal-title":"J Vasc Interv Radiol"},{"key":"710_CR37","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00270-020-02733-w","volume":"44","author":"M Sirakaya","year":"2021","unstructured":"Sirakaya M, O\u2019Balogun A, Kassamali RH. Superior rectal artery embolisation for haemorrhoids: what do we know so far? Cardiovasc Intervent Radiol. 2021;44:675\u201385.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"710_CR38","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s00270-021-02788-3","volume":"44","author":"A Alonso-Burgos","year":"2021","unstructured":"Alonso-Burgos A. Interventional radiology should be competitive-if haemorrhoids are arteriovenous connections, it is now the time for liquids? Cardiovasc Intervent Radiol. 2021;44:686\u20138.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"710_CR39","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.asjsur.2021.09.047","volume":"45","author":"TD Allahverdi","year":"2022","unstructured":"Allahverdi TD. Hemorrhoid treatment with injection of n-butyl-2-cyanoacrylate substance and its results: a single-center retrospective study. Asian J Surg. 2022;45:1128\u20139.","journal-title":"Asian J Surg"},{"key":"710_CR40","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00270-022-03081-7","volume":"45","author":"J Urbano","year":"2022","unstructured":"Urbano J. A recurring concern: is the animal model of rectal artery embolisation reproducible in humans? Cardiovasc Intervent Radiol. 2022;45:520\u20131.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"710_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/gels9050378","volume":"9","author":"A Pal","year":"2023","unstructured":"Pal A, Blanzy J, Rosas G\u00f3mez KJ, Preul MC, Vernon BL. Liquid embolic agents for endovascular embolisation: a review. Gels. 2023;9:378.","journal-title":"Gels"},{"key":"710_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10214841","volume":"10","author":"F Piacentino","year":"2021","unstructured":"Piacentino F, Fontana F, Curti M, Macchi E, Coppola A, Ossola C, et al. Non-adhesive liquid embolic agents in extra-cranial district: state of the art and review of the literature. J Clin Med. 2021;10:4841.","journal-title":"J Clin Med"},{"key":"710_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s42155-023-00347-0","volume":"6","author":"P Rabuffi","year":"2023","unstructured":"Rabuffi P, Bruni A, Antonuccio EMG, Saraceni A, Vagnarelli S. Transarterial embolisation of acute non-neurologic bleeding using ethylene-vinyl alcohol copolymer (EVOH) as first-line embolic agent. CVIR Endovasc. 2023;6:2.","journal-title":"CVIR Endovasc"},{"key":"710_CR44","doi-asserted-by":"crossref","unstructured":"G\u00fcnkan A, Ferreira MY, Vilardo M, Scarcia L, Bocanegra-Becerra JE, Alexandre A, et al. Safety and efficacy of newer liquid embolic agents Squid and PHIL in endovascular embolisation of cerebral arteriovenous malformations and dural arteriovenous fistulas: a systematic review and meta-analysis. Interv Neuroradiol. 2024:15910199241288897.","DOI":"10.1177\/15910199241288897"},{"key":"710_CR45","doi-asserted-by":"publisher","first-page":"280","DOI":"10.21037\/qims.2018.04.03","volume":"8","author":"R N\u00e9","year":"2018","unstructured":"N\u00e9 R, Chevallier O, Falvo N, Facy O, Berthod PE, Galland C, et al. Embolisation with ethylene-vinyl alcohol copolymer (Onyx\u00ae) for peripheral hemostatic and non-hemostatic applications: a feasibility and safety study. Quant Imaging Med Surg. 2018;8:280\u201390.","journal-title":"Quant Imaging Med Surg"},{"key":"710_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s42155-020-00117-2","volume":"3","author":"AL Salaskar","year":"2020","unstructured":"Salaskar AL, Razjouyan F, Cho AL, Sood RR, Akman A, Scher D, et al. Single institutional experience of peripheral applications of a liquid embolic agent: ethylene vinyl alcohol copolymer. CVIR Endovasc. 2020;3:38.","journal-title":"CVIR Endovasc"},{"key":"710_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59040710","volume":"59","author":"R Minici","year":"2023","unstructured":"Minici R, Venturini M, Fontana F, Guzzardi G, Pingitore A, Piacentino F, et al. Efficacy and safety of ethylene-vinyl alcohol (EVOH) copolymer-based non-adhesive liquid embolic agents (NALEAs) in transcatheter arterial embolisation (TAE) of acute non-neurovascular bleeding: a multicenter retrospective cohort study. Medicina (Kaunas). 2023;59:710.","journal-title":"Medicina (Kaunas)"},{"key":"710_CR48","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3174\/ajnr.A5203","volume":"38","author":"DF Vollherbst","year":"2017","unstructured":"Vollherbst DF, Sommer CM, Ulfert C, Pfaff J, Bendszus M, M\u00f6hlenbruch MA. Liquid embolic agents for endovascular embolisation: evaluation of an established (Onyx) and a novel (PHIL) embolic agent in an in vitro AVM model. AJNR Am J Neuroradiol. 2017;38:1377\u201382.","journal-title":"AJNR Am J Neuroradiol"},{"key":"710_CR49","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.3390\/jcm10112520","volume":"10","author":"M Venturini","year":"2021","unstructured":"Venturini M, Piacentinoa F, Coppola A, Bettoni V, Macchi E, De Marchi G, et al. Visceral artery aneurysms embolisation and other interventional options: State of the art and new perspectives. J Clin Med. 2021;10:2520.","journal-title":"J Clin Med"},{"key":"710_CR50","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.jvir.2021.05.014","volume":"32","author":"M Sapoval","year":"2021","unstructured":"Sapoval M, Vidal V, D\u00e9an C, Del Giudice C, Tradi F, Chevallier O, et al. Safety and efficacy of peripheral embolisation with EASYX liquid embolic agent: a multicenter prospective study. J Vasc Interv Radiol. 2021;32:1136\u201343.","journal-title":"J Vasc Interv Radiol"},{"key":"710_CR51","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.jvs.2020.10.069","volume":"73","author":"O Scallan","year":"2021","unstructured":"Scallan O, Kribs S, Power AH, DeRose G, Duncan A, Dubois L. Onyx versus coil embolisation for the treatment of type II endoleaks. J Vasc Surg. 2021;73:1966\u201372.","journal-title":"J Vasc Surg"},{"key":"710_CR52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.avsg.2020.02.013","volume":"67","author":"GD Mozes","year":"2020","unstructured":"Mozes GD, Pather K, Oderich GS, Mirza A, Colglazier JJ, Shuja F, et al. Outcomes of Onyx\u00ae embolisation of type II endoleaks after endovascular repair of abdominal aortic aneurysms. Ann Vasc Surg. 2020;67:223\u201331.","journal-title":"Ann Vasc Surg"},{"key":"710_CR53","doi-asserted-by":"publisher","first-page":"797","DOI":"10.21037\/qims-20-808","volume":"11","author":"S Gautier","year":"2021","unstructured":"Gautier S, Chevallier O, Mastier C, d\u2019Athis P, Falvo N, Pilleul F, et al. Portal vein embolisation with ethylene-vinyl alcohol copolymer for contralateral lobe hypertrophy before liver resection: safety, feasibility and initial experience. Quant Imaging Med Surg. 2021;11:797\u2013809.","journal-title":"Quant Imaging Med Surg"},{"key":"710_CR54","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.diii.2025.02.001","volume":"106","author":"R Loffroy","year":"2025","unstructured":"Loffroy R, Kobeiter H, Vidal V, Frandon J, Pellerin O, Dean C, et al. Ethylene-vinyl alcohol copolymer-based non-adhesive liquid embolic agent for transcatheter arterial embolisation in patients with abdominal\/pelvic arterial bleeding: a prospective, single-arm, multicenter cohort study. Diagn Interv Imaging. 2025;106:226\u201336.","journal-title":"Diagn Interv Imaging"},{"key":"710_CR55","doi-asserted-by":"publisher","DOI":"10.5797\/jnet.ra.2024-0073","volume":"19","author":"T Kojima","year":"2025","unstructured":"Kojima T, Maeda T, Ito Y, Kikuta H, Fujii M. Onyx liquid embolic agent: basic knowledge for its use in interventional neuroradiology. Journal of Neuroendovascular Therapy. 2025;19:2024\u20130073.","journal-title":"Journal of Neuroendovascular Therapy"},{"key":"710_CR56","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2214\/AJR.19.21508","volume":"214","author":"E Mahdjoub","year":"2020","unstructured":"Mahdjoub E, Serhal A, Males L, Tligui M, Hermieu JF, Khalil A, et al. Ethylene-vinyl alcohol copolymer embolisation for acute renal haemorrhage: initial experience in 24 cases. AJR Am J Roentgenol. 2020;214:465\u201371.","journal-title":"AJR Am J Roentgenol"},{"key":"710_CR57","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s00270-016-1432-0","volume":"39","author":"N Thulasidasan","year":"2016","unstructured":"Thulasidasan N, Sriskandakumar S, Ilyas S, Sabharwal T. Renal angiomyolipoma: Mid- to long-term results following embolisation with Onyx. Cardiovasc Intervent Radiol. 2016;39:1759\u201364.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"710_CR58","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s00270-025-04164-x","volume":"48","author":"J S\u00e9dat","year":"2025","unstructured":"S\u00e9dat J, Fontas E, Arnoffi P, Stranieri G, Colomb F, Chau Y. Prostatic artery embolisation using ethylene vinyl alcohol (EVOH) copolymer for benign prostatic hyperplasia: twelve-month analysis. Cardiovasc Intervent Radiol. 2025;48:1369\u201375.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"710_CR59","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jvir.2016.12.1220","volume":"28","author":"PH Kim","year":"2017","unstructured":"Kim PH, Tsauo J, Shin JH, Yun SC. Transcatheter arterial embolisation of gastrointestinal bleeding with N-butyl cyanoacrylate: A systematic review and meta-analysis of safety and efficacy. J Vasc Interv Radiol. 2017;28:522\u201331.","journal-title":"J Vasc Interv Radiol"},{"key":"710_CR60","first-page":"881","volume":"57","author":"C Hua","year":"2019","unstructured":"Hua C, Duvnjak M, Cheng J. Imaging evaluation of vascular malformations. Radiol Clin North Am. 2019;57:881\u201393.","journal-title":"Radiol Clin North Am"},{"key":"710_CR61","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.diii.2021.03.004","volume":"102","author":"O Chevallier","year":"2021","unstructured":"Chevallier O, Comby PO, Guillen K, Pellegrinelli J, Mouillot T, Falvo N, et al. Efficacy, safety and outcomes of transcatheter arterial embolisation with N-butyl cyanoacrylate glue for non-variceal gastrointestinal bleeding: a systematic review and meta-analysis. Diagn Interv Imaging. 2021;102:479\u201387.","journal-title":"Diagn Interv Imaging"},{"key":"710_CR62","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00261-017-1267-4","volume":"43","author":"G Abdulmalak","year":"2018","unstructured":"Abdulmalak G, Chevallier O, Falvo N, Di Marco L, Bertaut A, Moulin B, et al. Safety and efficacy of transcatheter embolisation with Glubran\u00ae2 cyanoacrylate glue for acute arterial bleeding: A single-center experience with 104 patients. Abdom Radiol. 2018;43:723\u201333.","journal-title":"Abdom Radiol"},{"key":"710_CR63","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/17474124.2020.1790355","volume":"14","author":"R Loffroy","year":"2020","unstructured":"Loffroy R, Mouillot T, Bardou M, Chevallier O. Current role of cyanoacrylate glue transcatheter embolisation in the treatment of acute nonvariceal gastrointestinal bleeding. Expert Rev Gastroenterol Hepatol. 2020;14:975\u201384.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"710_CR64","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s00330-025-11983-6","volume":"36","author":"R Loffroy","year":"2026","unstructured":"Loffroy R, Quirantes A, Tomassoni MT, Fouad M, Comby PO, Aho-Gl\u00e9l\u00e9 LS, et al. One-year outcomes of glue prostate-artery-embolization for symptomatic benign prostatic hyperplasia: a single-center retrospective cohort study. Eur Radiol. 2026;36:2317\u201328.","journal-title":"Eur Radiol"},{"key":"710_CR65","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00270-024-03743-8","volume":"47","author":"T Bilhim","year":"2024","unstructured":"Bilhim T, B\u00f6ning G, Guiu B, Luz JH, Denys A. CIRSE standards of practice on portal vein embolisation and double vein embolisation\/liver venous deprivation. Cardiovasc Intervent Radiol. 2024;47:1025\u201336.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"710_CR66","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ejrad.2008.10.017","volume":"73","author":"F Baltacio\u011flu","year":"2010","unstructured":"Baltacio\u011flu F, Cim\u015fit NC, Bostanci K, Y\u00fcksel M, Kodalli N. Transarterial microcatheter glue embolisation of the bronchial artery for life-threatening hemoptysis: technical and clinical results. Eur J Radiol. 2010;73:380\u20134.","journal-title":"Eur J Radiol"},{"key":"710_CR67","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00270-022-03160-9","volume":"45","author":"AM Ierardi","year":"2022","unstructured":"Ierardi AM, Carrafiello G. Spontaneous haematomas and embolisation: the challenging choice of the embolic agent. Cardiovasc Intervent Radiol. 2022;45:1007\u20139.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"710_CR68","first-page":"984","volume":"48","author":"R Jahan","year":"2001","unstructured":"Jahan R, Murayama Y, Gobin YP, Duckwiler GR, Vinters HV, Vi\u00f1uela F. Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery. 2001;48:984\u201395.","journal-title":"Neurosurgery"},{"key":"710_CR69","volume":"14","author":"S Ghatge","year":"2022","unstructured":"Ghatge S, Itti P. Curative embolization of small brain arteriovenous malformations by ethyl vinyl alcohol copolymer: a systematic review and meta-analysis. Cureus. 2022;14:e27219.","journal-title":"Cureus"},{"key":"710_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s42155-019-0051-7","volume":"2","author":"M Venturini","year":"2019","unstructured":"Venturini M, Lanza C, Marra P, Colarieti A, Panzeri M, Augello L, et al. Transcatheter embolisation with Squid, combined with other embolic agents or alone, in different abdominal diseases: A single-center experience in 30 patients. CVIR Endovasc. 2019;2:8.","journal-title":"CVIR Endovasc"}],"container-title":["CVIR Endovascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-026-00710-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42155-026-00710-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-026-00710-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T03:56:16Z","timestamp":1780026976000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42155-026-00710-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["710"],"URL":"https:\/\/doi.org\/10.1186\/s42155-026-00710-x","relation":{},"ISSN":["2520-8934"],"issn-type":[{"value":"2520-8934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RL serves as a consultant for GEM, Balt, Medtronic, and Guerbet. All other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}